T1	intervention 29 92	live and telemedicine deliveries of an imagery-based behavioral
T2	eligibility 336 383	Breast cancer survivors >6 weeks post-treatment
T3	control 598 619	waitlist control (WL)
T5	intervention-participants 585 587	23
T4	intervention-participants 511 513	48
T6	control-participants 631 633	47
T7	duration 741 748	3-month
T8	outcome 1422 1431	LD and TD
T9	outcome 1259 1357	fatigue, cognitive dysfunction, sleep disturbance, and health-related and breast cancer-related QO
T10	outcome-Measure 760 793	Seven self-report measures of QOL
